Expensive new meds increase drug expenditures in the North Carolina Medicaid program

October 05, 2004

As states continue to struggle to find ways to control Medicaid costs, a new study published in the September/October issue of Annals of Family Medicine finds that an increase in the number of prescriptions for new and more expensive medications resulted in a significant rise in drug costs in one state's Medicaid program.

Analyzing claims for more than 1,204,000 North Carolina Medicaid enrollees between 1998 and 2000, researchers from the University of North Carolina at Chapel Hill found that prescription drug coverage costs rose 22.8 percent annually during the study period, from $503 per person per year in 1998 to $759 in 2000. The average number of prescriptions filled per person per year also increased - from 13 in 1998 to 15.5 in 2000.

The authors point out that increased prescribing for six drugs (Prilosec, Zyprexa, Risperdal, Prevacid, Celebrex and Claritin) accounted for more than 25 percent of the total increase in expenditures. They add that some of the drugs with the greatest expenditures in this study are among those with the largest marketing budgets, and they note that for most of the newer drugs, improved cost-effectiveness has not been shown.

To help control rising prescription drug expenditures, they authors suggest that efforts should be undertaken to improve appropriate and cost-effective prescribing.

They note that prescription drug expenditures are the most rapidly growing component of total health care expenditures, and the widespread growth in prescription expenditures has particularly affected state Medicaid programs.

A possible solution to the issue of rising prescription costs is offered in a study by McMullin and colleagues also in the September/October 2004 issue of Annals of Family Medicine. Their study findings point to the effectiveness of electronic decision support systems in lowering prescription expenditures.
Annals of Family Medicine is a peer-reviewed research journal that provides a cross-disciplinary forum for new, evidence-based information affecting the primary care discipline. Launched in May 2003, the journal is sponsored by six family medical organizations, including the American Academy of Family Physicians, the American Board of Family Practice, the Society of Teachers of Family Medicine, the Association of Departments of Family Medicine, the Association of Family Practice Residency Directors and the North American Primary Care Research Group. The journal is published six times each year and contains original research from the clinical, biomedical, social and health services areas, as well as contributions on methodology and theory, selected reviews, essays and editorials. A board of directors with representatives from each of the sponsoring organizations oversees Annals. Complete editorial content and interactive discussion groups can be accessed free of charge on the journal's Web site, www.annfammed.org.

American Academy of Family Physicians

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.